FP-1039: Additional Phase Ib data

Data from 18 evaluable patients with untreated, unresectable mesothelioma in Arm C of an open-label, international Phase Ib trial showed that once-weekly 10 and 15

Read the full 257 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE